The Italian Medicines Agency (AIFA) has ordered the withdrawal of two batches of the drug SIMVASTATINA from pharmacies of Mylan Italia Spa, approved for the treatment of hypercholesterolemia and the prevention of cardiovascular disease.
Specifically, these are the lots: n. 8053537 to 09-2019 of the drug SIMVASTATINA MY * 10CPR 20MG – AIC 037398029 and n. 8052326 to 9-2019 of the drug SIMVASTATINA MY * 28CPR 20MG – AIC 037398056. The determination underlines Giovanni D & # 39; agata, president of "Sportello dei Diritti", was in need of a warning from the Czech authorities. Subsequent communication from Mylan on unspecified results in stability investigations
Mylan Italia Srl has announced the beginning of the withdrawal procedure, which the Carabinieri Commando for the Protection of Health – Nas will be asked to verify. 19659002]
READ THIS NEWS ABOUT OGGISCUOLA
Comments are closed.